United States, Bristol-Myers Squibb headquarters.

During this period, Bristol-Myers Squibb's performance was very good.

In addition to traditional medicine and equipment sales, the most important thing is the severe lung disease treatment center established in Maple Leaf Country in cooperation with Changtian Technology, which is running very well.

At present, thousands of patients have been successfully treated, and the total revenue will soon exceed 1 billion meters.

This is a real money printing machine.

Although the financial report for 2007 has not yet come out, Bristol-Myers Squibb can be sure that the revenue and profit of the group company will hit a record high last year.

Such achievements are inseparable from the cooperation between Changtian Technology.

Bristol-Myers Squibb's vice president Cassian, although there were some unpleasant things with Changtian Technology during the first negotiation, but the final result was good, so Cassian was highly valued by the group company.

In 2008, Mr. Burgart, CEO of the group company, will retire.

Whether it is the senior management or the board of directors of the group company, they all hope that Cassian can be elected as the head of Bristol-Myers Squibb.

Becoming the head of Bristol-Myers Squibb means having more resources and better wealth.

Among other things, the intensive care center that cooperates with Changtian Technology, those brokers who are related to the senior executives of the company group, can get quite a lot of commissions for introducing a big client to treat them by jumping in the line.

If Cassian can be successfully elected as the CEO of Bristol-Myers Squibb, the profits behind it are self-evident.

Western pharmaceutical companies.

Everything is business.

Just when Cassian was planning for the future campaign.

Bristol-Myers Squibb suddenly received an urgent letter from Changtian Technology.

In the letter, the Social Security Department was requested to do everything possible to supply Osimertinib to Changtian Technology within a week.

If Bristol-Myers Squibb cannot complete the corresponding work according to the requirements of Changtian Technology, then Changtian Technology will immediately terminate the comprehensive cooperation with Bristol-Myers Squibb.

Seeing such a letter from Changtian Technology, Cassian's back felt a little chilled.

As an executive of a pharmaceutical company, Xia Guo has made various efforts during this period, and everyone knows that he hopes to get Osimertinib.

Cassian also knew that the target of using Osimertinib was not ordinary people, but experts in Xia Guo's aeroengines.

Although osimertinib is still in the experimental process, judging from the current animal experiments and clinical experiments, the effect is quite good.

Therefore, many pharmaceutical giants and industry experts in the United States predict that after the launch of Osimertinib, it will definitely become the most popular targeted drug for mid-to-late cancer in the world.

Now that Changtian Technology is putting pressure on Bristol-Myers Squibb so bluntly, this is something Cassian did not expect.

At the beginning, Bristol-Myers Squibb and Changtian Technology cooperated, because Changtian Technology was in a strong position, so the two parties did not sign any compensation for Changtian Technology's sudden termination of the contract.

That is to say, in the process of cooperation between the two parties, Changtian Technology has been in a strong position from the beginning to the end.

Changtian Technology can terminate the contract at any time and terminate the cooperation at any time without any compensation.

Now that Changtian Technology is desperately putting pressure on Bristol-Myers Squibb, it is obviously going all out.

This practice of Changtian Technology is definitely in violation of the relevant norms of the United States.

But whocare?

The hard fist is the boss.

The income of the intensive care center has become the biggest profit point of Bristol-Myers Squibb.

If Bristol-Myers Squibb loses such a large profit point, it will not be worth the candle.

There are many things. If you can take tonics, you can’t take laxatives, and it’s hard to spit out when you eat them.

This letter requires a very tight schedule, and the corresponding medicines will be provided within a week.

Cassian didn't dare to make decisions without authorization, and immediately reported the relevant situation to the company's senior management.

The top management of Bristol-Myers Squibb held an emergency meeting. After discussion, all the top management agreed that the Maple Leaf National Intensive Care Center, which was finally established with great difficulty, cannot be arbitrarily cancelled.

Bristol-Myers Squibb will exhaust all means to obtain related drugs from AstraZeneca.

Chen Xiao's guess was not wrong at all.

Several giant pharmaceutical companies in the United States restrict each other and cooperate with each other.

Bristol-Myers Squibb definitely has a trump card that AstraZeneca fears.

At the same time, companies such as Johnson & Johnson and Pfizer also received letters.

The situation of the two companies is the same as that of Bristol-Myers Squibb. They both cooperate with Changtian Technology, and the profits are very rich.

If you lose the cooperation with Changtian Technology because of such a small matter, it is really not worth the loss.

Among them, Pfizer's annual profits from intensive care in Mexico are already higher than some of Pfizer's branded drugs.

Businessmen pursue profits, and it is more painful for them to lose this profit than to cut their flesh.

Companies such as Pfizer acted urgently to start negotiations with AstraZeneca.

Ask AstraZeneca to be able to provide osimertinib immediately.

Pfizer and AstraZeneca also have many scientific and technological cooperation.

In terms of cancer-targeted drugs, the two parties actually share patents.

So now AstraZeneca is facing a dilemma.

On the one hand, there is pressure from the relevant departments of the United States, requiring AstraZeneca to prohibit the supply of any targeted drugs to Xia Guo.

On the other hand, this is the pressure from US capital.

The capital behind the pharmaceutical companies represented by Pfizer, Johnson & Johnson, and Bristol-Myers Squibb is a request that AstraZeneca can immediately provide relevant drugs as soon as possible, so as to calm the anger from Xia Guochangtian Technology.

American politics is in the service of capital.

All political decisions are to allow capital to proliferate better.

So AstraZeneca has little choice but to compromise with capital.

He provided osimertinib to the three companies at the first time.

The reason for doing this, AstraZeneca still has its own considerations.

Even if the relevant departments of the United States are offended and fined, such losses are much more cost-effective than offending Bristol-Myers Squibb & Johnson, Pfizer, and the capital behind them.

AstraZeneca's volume is placed there, and there are still many patents on medicines and equipment in hand.

It is absolutely impossible for the relevant departments of the United States to make AstraZeneca disappear because of this incident.

And at this moment, in Tianyue Island of Xia Kingdom, the intensive care center.

Qu Ping's team is nervously completing the joint colony and lung resection for He Jiang.

He Jiang's lungs are quite fragile.

Long-term bed rest greatly increased his chances of lung infection.

If the lungs are not removed at this time, even if the combined colony operation is successful, the infection of the lungs will cause He Jiang to be critically ill.

Therefore, Qu Ping's team, together with relevant medical staff from the Fudan University Cancer Center, took the risk and urgently performed surgery on He Jiang.

The leaders and colleagues of the 606 institute were not feeling well.

They came this time to hope that He Jiang could explain some technical work.

Unexpectedly, the day he saw He Jiang, He Jiang lay on the bed and couldn't say a word at all.

The colleagues in Institute 606 could feel that He Jiang was very eager to communicate with everyone, but his physical condition did not allow it.

So now they can only hope that the operation will be successful.

If the operation fails, even if my turbofan 10 engine can be finally perfected, I don’t know if it will be in the Year of the Monkey.

The Institute is already in a race against time.

The relevant departments of the Xia Kingdom. I also learned that the country is undergoing surgery.

Moreover, the news from He Jiang's treatment team at the Affiliated Hospital of Fudan University is that the chance of He Jiang's surgery being successful is very low, and the leaders of relevant departments are asked to prepare for the worst.

After Liang Fei got the news, his heart was very heavy, and his heart was extremely angry.

He felt that some things should not be hidden.

Why is there such a situation as He Jiang?

The most important reason is that many pharmaceutical scientific research institutions in China are overstaffed. They are all trying to make money and cheat scientific research funds. No one can settle down to engage in scientific research.

The establishment of a cancer-targeted drug project actually started 20 years ago.

But in the past 20 years, no matter where the scientific research projects stand, the number of people actually engaged in related scientific research is very small.

Why?

This somewhat deformed scientific research environment is inseparable.

A scientific research that has lasted for more than 10 years, if you do not come up with any achievements in the end, these 10 years of time will be wasted, and the funds will be in vain.

Of those experts and researchers who can stand in the experiments of scientific research institutes, which one is not the top of the pyramid?

After studying hard for decades, I finally came to this position, and I took it for granted that I wanted to make as much money as possible.

Therefore, many projects with quick results are done in a big way.

And those projects that need to settle down and move forward one step at a time, no one cares about them at all.

This is the fundamental reason why Xiaguo's Internet applications have been greatly developed in a short period of time, while anti-cancer targeted drugs and chip technology have stagnated.

Because doing Internet application development, you can get huge profits in a very short period of time.

As for making chips or targeted drugs for cancer, it is very likely that you have worked hard for decades in obscurity, without any results, only hard work without return.

Liang Fei reported this matter to the senior officials of Yanjing, and hoped that Xia Guo TV would truthfully announce He Jiang's deeds and related situations.

The purpose of doing this is to inspire the scientific research workers in Xiaguo, especially those young people who are about to enter the scientific research industry.

We must be aware of the severe situation that Xia Guo is currently facing in the high-end pharmaceutical industry, and encourage everyone not to care about temporary gains and losses, and do research with peace of mind.

Most of Xia Guo's elites earned some quick and short-term projects.

After a project is completed, there may be tens of millions of income soon.

But if you really settle down, do research well, and make breakthroughs in projects such as cancer-targeted drugs that require long-term research and investment, then the mobile phone you get may cost hundreds of millions or even tens of billions of dollars.

The rose of time is especially fragrant in scientific research projects, but many people are unwilling to wait.

After receiving the instructions from the relevant departments, about He Jiang's deeds of making a turbofan 10 engine, which has been unknown for decades, and the United States has tried every means to block access to targeted drugs such as osimertinib in the country. And other related news were overwhelmingly reported in Xia Country.

In addition to Xiaguo TV, heavyweight paper media such as "Global Times", "Shan Xiao", "Yanjing Daily", as well as online media such as Xinlang and Souhu are frantically reporting.

Countless ordinary people in the Xia Kingdom felt very angry when they saw such news, and they also felt worried and anxious about He Jiang's condition.

"White Pig is really bad! In order to kill one of our engineers, the diagnosis did everything possible to ban the sale of drugs!"

"I also saw a lot of anger, but I can't say that. All the current measures of the American company are in line with the relevant requirements of the United States. After all, targeted drugs for late-stage cancer like oxetirizine are originally in the experimental process. There is no external sales, and even if they are sold externally, they have no cooperation agreement with us, so it is normal for the other party not to provide drugs.”

"I feel very sad! The lives of Chinese people depend on the medicine of foreigners!"

"Extremely angry! Why can't we produce a drug with the same effect?"

"I fully understand the feelings upstairs, but the production of anticancer drugs is not a simple matter. It involves many industries, especially the life science industry. There is a huge gap between our country and the United States in basic science. The foundation is decades away, let alone such a high-tech achievement."

"What about Changtian Technology? Isn't Changtian Technology very powerful? Why is there no way to save Professor He Jiang?"

"Please use your brain when you speak upstairs. Changtian Technology has only been established for a few years? It is quite remarkable to be able to achieve today's achievements! You can't ask a private company to fight alone and compete with the entire elite team in the United States !"

"I agree with the speech above! When you are sneering at Changtian Technology, UU Reading www.uukanshu.com should think about Xia Guo's many pharmaceutical companies and research institutes. Don't even dare to let it go!"

At this time, in Changzezhou, Suzhou and Hangzhou.

The coping strategies given by Chen Xiao are indeed very effective.

Whether it is Bristol-Myers Squibb, Pfizer, Johnson & Johnson, etc., they immediately provided Changtian Technology with osimertinib, which is currently in the experimental stage.

Moreover, these companies have guaranteed to Changtian Technology that all the medicines are from AstraZeneca, the medicines are sufficient, and there is no legal or economic risk.

When Qu Ping was the first to get the news, she excitedly trot to Chen Xiao's office to report to Chen Xiao.

Qu Ping knew about He Jiang's situation, and it was very likely that after taking osimertinib, she would not be able to completely cure her, so she could only prolong her life as much as possible.

But this drug is better than nothing.

When Chen Xiao got such news, she didn't seem very happy.

He had expected such a result.

After all, with huge profits, the three pharmaceutical companies that were notified will definitely do everything possible.

But this kind of head-on fisting, Chen Ling felt that it should be done a few times less.

Changtian Technology still needs to be stronger, so strong that just raising your fist will make others feel intimidated, instead of letting the other party try your fist.

United States, a certain intelligence department.

Perito, who was in charge of the He Jiang project, slammed the table angrily after learning that Changtian Technology had obtained the drug!

Bellito believes that what Changtian technologists do is to fly above their own heads!